Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021

IPD Insider Trading (ImpediMed)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$21,065.28
Insider Selling (Last 12 Months): A$0.00

ImpediMed Insider Trading History Chart

ImpediMed Share Price & Price History

A$0.00
+0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021

ImpediMed Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/7/2021Judith DownesInsiderBuy299,648A$0.04A$11,086.98
4/1/2021Amit PatelInsiderIssued200,893A$0.11A$22,098.23
1/4/2021Judith DownesInsiderIssued105,733A$0.13A$14,062.49
11/16/2020Richard CarreonInsiderIssued631,000A$0.10A$60,576.00
10/7/2020Robert (Bob) GrahamInsiderBuy269,684A$0.04A$9,978.31
7/1/2020Judith DownesInsiderIssued213,068A$0.07A$14,062.49
5/1/2020Robert (Bob) GrahamInsiderTransfer773,186A$0.04A$30,154.25
4/29/2020Judith DownesInsiderIssued143,175A$0.04A$5,583.83
1/2/2020Gary GoetzkeInsiderIssued137,195A$0.18A$24,009.13
7/24/2019Judith DownesInsiderIssued27,534A$0.11A$3,028.74
7/16/2019Richard CarreonInsiderExercise139,366A$0.11A$15,330.26
3/20/2019Amit PatelInsiderBuy88,000A$0.23A$19,800.00
3/13/2019Donald (Don) WilliamsInsiderBuy10,000A$0.24A$2,350.00
3/11/2019Scott WardInsiderBuy25,000A$0.24A$5,875.00
3/8/2019Donald (Don) WilliamsInsiderBuy10,000A$0.24A$2,400.00
3/6/2019Donald (Don) WilliamsInsiderBuy80,000A$0.25A$20,000.00
See Full Table
ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
Read More on ImpediMed

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

1,616,138 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ImpediMed?

ImpediMed's top insider shareholders include:
  1. Amit Patel (Insider)
  2. Gary Goetzke (Insider)
  3. Judith Downes (Insider)
  4. Richard Carreon (Insider)
  5. Robert (Bob) Graham (Insider)
Gain the Knowledge You Need to Successfully Trade Futures Markets
Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.
Download Your Complimentary Technical Analysis Guide TODAY!
pixel